Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

3.12
Delayed Data
As of Jun 23
 +0.03 / +0.97%
Today’s Change
1.65
Today|||52-Week Range
5.70
+79.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues3.4M55.5M24.5M33.7M
 
 
 
 
 
Cost of Goods Sold0.00----7.6M
 
 
Depreciation And Amortization94.0K139.0K223.0K3.7M
 
 
 
 
 
 
Operating ExpensesGross Income3.3M----22.4M
 
 
 
General Expenses80.5M85.9M84.3M156.6M
 
 
 
 
 
Research And Development56.7M57.4M40.8M38.0M
 
 
 
 
 
Total Operating Expenses80.6M86.1M84.5M167.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-77.2M-30.5M-60.1M-134.2M
 
 
 
 
 
Extraordinary Credit0.00--0.00123.9M
 
 
Extraordinary Charge0.00--0.00-3.0M
 
 
Interest Expense On Debt538.0K7.1M7.4M7.9M
 
 
 
 
 
Other Expenses0.000.00-39.0K-3.9M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-77.7M-37.5M-67.3M-24.4M
 
 
 
 
 
Income Taxes0.000.00-1.4M-133.0K
 
 
 
Net Income-77.7M-37.5M-68.7M-24.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.6M11.8M13.1M14.6M
 
 
 
 
 
Shares To Calculate EPS Diluted9.6M11.8M13.1M14.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$8.00-$3.20-$5.20-$1.68
 
 
 
 
 
EPS Diluted-$8.00-$3.20-$5.20-$1.68